Mitigating cost increases through preemptive care and clinical efficacy to reduce the disease burden of clinically at-risk patients.
Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Articles by Lonny Reisman, MD, Chief Executive Officer, HealthReveal
Advertisement
Latest Updated Articles
- Clinical Efficacy: A Cost Containment Weapon for the 21st Century
Published: August 18th 2015 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Prescription Access Crisis: 40% of GLP-1 RA Rx Are Unfilled
2
FDA Expands Upadacitinib Label for Treating Inflammatory Bowel Disease
3
Pediatric Atopic Dermatitis Treatment Selection: Biologics vs Nonsteroidal Topical Therapies
4
Efficacy and Safety of Dupilumab in AD Across Diverse Pediatric Populations: A Q&A With Elaine Siegfried, MD
5
